Breast cancer

Exam relevance: in 77 of more than 150 board exam reports · rank 1

Synonyms
breast carcinoma
Specialty
Gynaecology · Breast
Images
Ultrasound 4 · Mammography/MRI 4 · Endoscopy & gross 2 · Clinical 2
Exam relevance
77 of more than 150 reports · rank 1
In the app
5 flashcards · GynFuchs
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (12)
  2. Classification
  3. Aetiopathogenesis
  4. Clinical features
  5. Histology
  6. Diagnosis
  7. Treatment principles
  8. Keep learning in the app
  9. Further reading (selection)
  10. Cross-references

Images (12)

Breast cancer – Breast ultrasound: hypoechoic, ill-defined lesion with posterior acoustic shadowingUltrasound
Breast ultrasound: hypoechoic, ill-defined lesion with posterior acoustic shadowingImage: SCiardullo, “Caso 1 Ecografia 1” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Breast cancer – Mammogram CC view, bilateral: dense glandular tissue (ACR c/d) with no mass or microcalcificationsMammography/MRI
Mammogram CC view, bilateral: dense glandular tissue (ACR c/d) with no mass or microcalcificationsImage: SCiardullo, “Caso 1 Mamografía CC” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Breast cancer – endoscopyEndoscopy & gross
Breast cancer – endoscopyImage: Guo M, Liu G, Han X, Jiao R, Li J. (Frontiers in oncology 2026) · CC BY 4.0 · Source
Breast cancer – clinical photo
Breast cancer – clinical photoImage: SCiardullo (Wikimedia Commons) · CC BY-SA 4.0 · Source
Breast cancer – Breast ultrasound: the same lesion taller-than-wide — vertical orientation as a criterion for malignancyUltrasound
Breast ultrasound: the same lesion taller-than-wide — vertical orientation as a criterion for malignancyImage: SCiardullo, “Caso 1 Ecografía 3” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Breast cancer – Mammogram CC view, bilateral: fatty involution, density category ACR a/bMammography/MRI
Mammogram CC view, bilateral: fatty involution, density category ACR a/bImage: SCiardullo (Wikimedia Commons) · CC BY-SA 4.0 · Source · cropped
Breast cancer – endoscopyEndoscopy & gross
Breast cancer – endoscopyImage: Kalyan Kondeti ASSN, Venkitaraman B, Kajamohideen S. (Cureus 2026) · CC BY 4.0 · Source
Breast cancer – clinical photo
Breast cancer – clinical photoImage: SCiardullo, “Caso 1 Ecografía 2” (Wikimedia Commons) · CC BY-SA 3.0 · Source
Breast cancer – Breast ultrasound: oval, smooth-margined, homogeneously hypoechoic lesion, wider-than-tall — a typical fibroadenomaUltrasound
Breast ultrasound: oval, smooth-margined, homogeneously hypoechoic lesion, wider-than-tall — a typical fibroadenomaImage: Nevit Dilmen, “Breast US Fibroadenoma 0531094012531 Nevit” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Breast cancer – imaging: Spiculated mass (BI-RADS 5)Mammography/MRI
Spiculated mass (BI-RADS 5)Image: SCiardullo (Wikimedia Commons) · CC BY-SA 4.0 · Source
Breast cancer – Breast ultrasound: anechoic, well-defined cyst with posterior acoustic enhancementUltrasound
Breast ultrasound: anechoic, well-defined cyst with posterior acoustic enhancementImage: Nevit Dilmen, “Breast ultrasound 110302093640 0942031” (Wikimedia Commons) · CC BY-SA 3.0 · Source · cropped
Breast cancer – imagingMammography/MRI
Breast cancer – imagingImage: SCiardullo (Wikimedia Commons) · CC BY-SA 4.0 · Source
1 / 12

Classification

Molecular Subtypes

  • Luminal A: A Luminal A carcinoma is hormone receptor-positive, HER2-negative, well-differentiated with a low Ki-67.
  • Luminal B: A Luminal B carcinoma is hormone receptor-positive with a high Ki-67 or poorer grade, HER2 negative or positive.
  • Triple-negative: In triple-negative breast cancer: oestrogen receptor, progesterone receptor, and HER2 are all negative.

Aetiopathogenesis

BRCA and HRD

  • BRCA1/2 function: BRCA1 and BRCA2 are tumour suppressor genes involved in homologous recombination, which repair DNA double-strand breaks.
  • HRD definition: HRD means homologous recombination deficiency, i.e., the functional defect of this repair pathway even without a BRCA mutation.
  • Germline vs. somatic mutation: A germline mutation differs from a somatic mutation in that it is present in all body cells and can be inherited.

Clinical features

History

  • Regarding the finding itself, questions are asked about duration, change in size, pain, cyclical nature, and nipple discharge.
  • The family history records breast and ovarian cancers in relatives and their respective age at diagnosis.
  • The age of affected relatives at diagnosis is important because it is part of the score for indicating BRCA testing.

Inspection

  • In a sitting position, with arms lowered and raised, one looks for asymmetry, bulging, plateau sign, skin dimpling, and nipple retraction.
  • Peau d'orange is caused by lymphatic congestion in the cutis, which tethers the skin at the hair follicles.

Palpation

  • Technically, one palpates flat with the finger pads against a counter-pressure, systematically in all quadrants, in sitting and supine positions.
  • A lump typical of carcinoma is firm, poorly defined, has limited mobility, and is mostly painless.
  • Also palpated are the axilla as well as the infraclavicular and supraclavicular regions bilaterally.
  • The most common location is the upper outer quadrant, accounting for about half of all carcinomas.

More facts from the study questions

  • The typical palpation findings of a breast carcinoma are a firm consistency, poor demarcation from surrounding tissue and low mobility.
  • The correct sequence is: mammography before core needle biopsy.
  • A haematoma caused by the biopsy can significantly impair the interpretability of a subsequent mammogram.
  • After a suspicious palpable finding, ultrasound of both breasts and the axillae is the first imaging step.
  • It serves to further characterise the finding.
  • Approximately half of all breast carcinomas are located in the upper outer quadrant.
  • This area is examined with particular care during palpation.
  • An eczematous, scaly, erosive change of the nipple is suspicious for Paget's disease of the nipple.
  • The Elston and Ellis grading system is an established system for assessing the aggressiveness of breast carcinoma.
  • It is based on the histological evaluation of three criteria: tubule formation, nuclear pleomorphism and mitotic rate.

Histology

Mandatory Information

  • Histological type: The pathology report first states the histological type, i.e. invasive, no special type (NST), invasive lobular, or a special type.
  • Grading according to Elston and Ellis: This assesses the three criteria of tubule formation, nuclear pleomorphism, and mitotic rate.
  • Hormone receptor status: This includes the oestrogen and progesterone receptor status as a percentage of stained tumour cell nuclei.
  • HER2 status: The HER2 status is determined by immunohistochemistry and re-tested by FISH if 2+.
  • Ki-67: The proliferation marker Ki-67 measures the proportion of proliferating cells and thus the growth rate.

Diagnosis

Five malignant signs

  • Shape: A carcinoma is typically irregular, angular or spiculated.
  • Orientation: The orientation of a malignant lesion to the skin is mostly vertical, i.e., taller-than-wide.
  • Internal echoes: The internal echoes of a carcinoma are characteristically markedly hypoechoic and inhomogeneous.
  • Posterior phenomenon: Posterior to the lesion, there is often an acoustic shadow because the tumour is sound-absorbing and desmoplastic.
  • Surroundings: The surroundings of a carcinoma show an echogenic halo and infiltration instead of displacement.

Axilla and Doppler

  • Normal lymph node: An unremarkable axillary lymph node has a broad, echogenic fatty hilum and a narrow, hypoechoic cortex.
  • Lymph node suspicious for malignancy: A lymph node is suspicious for malignancy if it is round, shows an effaced hilum and an eccentrically thickened cortex.
  • Colour Doppler: In carcinoma, Colour Doppler often shows prominent, irregularly penetrating peripheral vessels, but is not conclusive on its own.

Limitations of Ultrasound

  • Necessity of mammography: Mammography remains indispensable because ultrasound does not reliably detect microcalcifications and thus DCIS.
  • Difficult to detect on mammography: Often difficult to detect on mammography are lobular carcinomas and LCIS, because they grow diffusely and show little density difference.

What the abbreviations stand for

  • BI-RADS stands for Breast Imaging Reporting and Data System of the American College of Radiology.
  • ACR in this context stands for the American College of Radiology, which defines density categories a to d.

Categories

  • BI-RADS 0 means assessment incomplete, further imaging or prior images are needed.
  • BI-RADS 4 means suspicious, subdivided into 4a to 4c — histological clarification required.

Density

  • ACR a and b describe predominantly fatty involuted glandular tissue with good mammographic assessability.
  • ACR c and d describe dense glandular tissue where the sensitivity of mammography is reduced.
  • In practice, high density means a higher risk of interval cancer and the importance of supplementary ultrasound.

Typical imaging findings

  • Ultrasound: The hypoechoic lesion stands perpendicular to the skin and is larger in depth than in width. Its margins are ill-defined and the internal structure heterogeneous; the calipers show the vertical diameter to be the larger one.
  • Ultrasound: The lesion is hypoechoic with ill-defined, angular margins and a heterogeneous internal structure. Marked posterior shadowing is seen behind it; the surrounding tissue planes appear interrupted and calipers span the lesion.
  • Mammography: Fine strands of differing length radiate in a stellate pattern from a dense centre into the surrounding tissue. The normal connective tissue strands are pulled towards this point; the lesion has no smooth margin and no bright halo.
  • Mammography: On the right there is a dense, irregularly bordered mass with fine spicules radiating into the surrounding tissue in a stellate fashion. The left side is normal by comparison; no microcalcification is visible within the lesion.

Treatment principles

  • Treatment is planned in an interdisciplinary tumour board according to stage and biological subtype.
  • Breast-conserving surgery followed by radiotherapy is used where possible, otherwise mastectomy; the axilla is usually assessed by sentinel lymph node biopsy.
  • Systemic therapy depends on the subtype: endocrine therapy for hormone receptor positive tumours, HER2-targeted therapy for HER2 positive tumours and chemotherapy according to risk, often given neoadjuvantly in aggressive subtypes.
  • Genetic counselling in familial cases, structured follow-up and psycho-oncological support are part of care.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Breast cancer with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 5 flashcards on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Breast Cancer (NCBI Bookshelf)
  2. German Guideline Program in Oncology: S3 guideline on breast cancer (German)
  3. DocCheck Flexikon, Mammakarzinom
  4. DocCheck Flexikon, Mammasonographie
  5. DocCheck Flexikon, BI-RADS
  6. DocCheck Flexikon, BRCA1

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Male breast cancer · Pregnancy-associated breast cancer · Non-puerperal mastitis

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.